Health and Life Sciences news
As cold and flu season ramps up – even in the midst of the COVID-19 pandemic – some people still follow the old adage of “Don’t go outside without a coat; you’ll catch a cold.”
A novel form of a drug used to treat osteoporosis that comes with the potential for fewer side effects may provide a new option for patients.
The time period between Thanksgiving and Christmas is characterized by overindulgence. While we tell others that we are eating and drinking in moderation, controlling our spending, and exercising more, in reality, we do the exact opposite. So where does this disconnect come from?
For pregnant women, the elderly and those with weakened immune systems, listeriosis is a serious foodborne illness often linked to deli meats, fresh produce and dairy products. Even with antibiotic treatment, listeriosis is fatal for about 20 percent of patients, resulting in thousands of deaths annually.
A new approach to cancer immunotherapy has the potential to be a universal treatment for solid tumors, according to researchers at Purdue University.
During the COVID-19 pandemic, health care professionals and researchers have been confined mostly to using local and national datasets to study the impact of comorbidities (chronic or long-term health conditions), pre-existing medication use, demographics and various interventions on disease course.
When cancer patients ask about the drug that may save their lives, they don’t expect to hear about zebrafish or fruit flies. Yet this is precisely where the life-saving treatments coming out of the Purdue University Center for Cancer Research begin.